OncoVista Innovative Therapies OVIT Stock
OncoVista Innovative Therapies Price Chart
OncoVista Innovative Therapies OVIT Financial and Trading Overview
| OncoVista Innovative Therapies stock price | 0.0001 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.0015 USD |
| Volume | 1K USD |
| Avg. Volume | 5.28K USD |
| Market Cap | 558.34K USD |
| Beta (5Y Monthly) | -53.069016 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OVIT Valuation Measures
| Enterprise Value | 422.74K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.124 |
Trading Information
OncoVista Innovative Therapies Stock Price History
| Beta (5Y Monthly) | -53.069016 |
| 52-Week Change | -86.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0015 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000192 USD |
| 200-Day Moving Average | 0.000143 USD |
OVIT Share Statistics
| Avg. Volume (3 month) | 5.28K USD |
| Avg. Daily Volume (10-Days) | 300 USD |
| Shares Outstanding | 23.56M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1.4749:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2014 |
| Most Recent Quarter (mrq) | September 30, 2015 |
| Next Fiscal Year End | December 31, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -2357.67% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3404057 USD |
| Net Income Avi to Common (ttm) | -3270377 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 61.27K USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 479.3K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.01 |
| Book Value Per Share (mrq) | -0.28 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -264361 USD |
| Levered Free Cash Flow (ttm) | -635235 USD |
Profile of OncoVista Innovative Therapies
| Country | United States |
| State | TX |
| City | San Antonio |
| Address | 14785 Omicron Drive |
| ZIP | 78245 |
| Phone | 210-677-6000 |
| Website | https://www.oncovista.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
Q&A For OncoVista Innovative Therapies Stock
What is a current OVIT stock price?
OncoVista Innovative Therapies OVIT stock price today per share is 0.0001 USD.
How to purchase OncoVista Innovative Therapies stock?
You can buy OVIT shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoVista Innovative Therapies?
The stock symbol or ticker of OncoVista Innovative Therapies is OVIT.
Which industry does the OncoVista Innovative Therapies company belong to?
The OncoVista Innovative Therapies industry is Biotechnology.
How many shares does OncoVista Innovative Therapies have in circulation?
The max supply of OncoVista Innovative Therapies shares is 5.58B.
What is OncoVista Innovative Therapies Price to Earnings Ratio (PE Ratio)?
OncoVista Innovative Therapies PE Ratio is now.
What was OncoVista Innovative Therapies earnings per share over the trailing 12 months (TTM)?
OncoVista Innovative Therapies EPS is 0 USD over the trailing 12 months.
Which sector does the OncoVista Innovative Therapies company belong to?
The OncoVista Innovative Therapies sector is Healthcare.